DBV Technologies S.A.
DBVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001613780
In the last 90 days, DBV Technologies S.A. insiders filed 0 open-market purchases and 1 sale; 78 institutions reported holding it in 13F filings for Q2 2026, worth $345.7M in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesDBVTF
Q3 2023 vs. Q2 2023
How the institutions holding DBV Technologies S.A. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 36 | 38 | +2 |
| Shares | 46.0M | 44.4M | −1.62M (−3.5%) |
| Value | $87.4M | $60.4M | −$27.1M (−30.9%) |
New holders (6)
Institutions that held DBV Technologies S.A. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Yiheng Capital Management, L.P. | 133,192 | $181.1K | 0.02% |
| Landscape Capital Management, L.L.C. | 68,911 | $93.7K | 0.01% |
| Tower Research Capital LLC (TRC) | 14,952 | $20.3K | 0.00% |
| XTX Topco Ltd | 14,426 | $19.6K | 0.00% |
| NBC Securities, Inc. | 4,000 | $5.00K | 0.00% |
| Cubist Systematic Strategies, LLC | 2,707 | $3.68K | 0.00% |
Sold out (4)
Institutions that held DBV Technologies S.A. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Logos Global Management LP | 1,200,000 | $2.28M |
| Cowen and Company, LLC | 50,986 | $96.9K |
| Envestnet Asset Management Inc | 22,494 | $42.7K |
| Group One Trading, L.P. | 277 | $526 |